117th Congress · House
Medical Marijuana Research Act
Subjects: Administrative law and regulatory procedures · Alternative treatments · Crime and Law Enforcement · Department of Health and Human Services · Drug safety, medical device, and laboratory regulation · Drug therapy · Drug trafficking and controlled substances · Food and Drug Administration (FDA)
In plain language
- House bill in the 117th Congress.
- Establishes a new, separate registration process to facilitate medical marijuana research.
- House passed it on Apr 5, 2022 (substantive).
Official summary (Congressional Research Service)
Medical Marijuana Research Act This bill establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
View this measure on congress.gov
Roll-call votes on this measure
- substantiveApr 5, 2022 · House · Passed
On Motion to Suspend the Rules and Pass, as Amended — H R 5657 — Medical Marijuana Research Act